Synergetics USA (SURG) Income Statement
Is this a real, growing, cash-generative business, or a story propped up by accounting?
of free cash flow goes to stock comp (was −0.0% in FY21). Owner-earnings math treats it as a real cost.
4.4mn → 20.1mn diluted shares since FY21. Rising share count dilutes EPS. Growth must outrun it.
−96.4% YoY in FY25 · 0.0% of revenue.
$0.0M returned vs $−21.3M of FCF in FY25. Free cash flow was negative, so returns were funded from the balance sheet rather than from cash generation.
-63¢ of every revenue dollar becomes profit. The biggest cost lever is COGS.
Over this window: gross 12.1% → -18.6%. Net margin -63.3% is below the sector median.
| Line item | TTM † | FY25 | FY24 | FY23 | FY22 | FY21 | YoY | CAGR 21→25 |
|---|---|---|---|---|---|---|---|---|
| Revenue & profitability | ||||||||
Revenue | 56,962.9 | 56,962.9 | 60,881.2 | 137,141.8 | 121,544.2 | 51,060.6 | ▼6.4% | +2.8% |
Cost of revenue | 67,551.8 | 67,551.8 | 75,205.4 | 101,499.3 | 108,074.8 | 44,890.6 | ▼10.2% | +10.8% |
Gross profit | −10,588.9 | −10,588.9 | −14,324.2 | 35,642.5 | 13,469.4 | 6,170.0 | ▲26.1% | — |
Research & development | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | — | — |
Selling, general & admin | 20,071.1 | 20,071.1 | 26,292.9 | 15,713.0 | 11,911.8 | 11,378.3 | ▼23.7% | +15.2% |
Total operating expenses | 23,548.0 | 23,548.0 | 27,458.2 | 16,777.1 | 12,835.6 | 12,162.5 | ▼14.2% | +18.0% |
Operating incomefeeds ROC rank | −34,136.9 | −34,136.9 | −41,782.4 | 18,865.4 | 633.8 | −5,992.6 | ▲18.3% | — |
Other income, net | −1,932.8 | −1,932.8 | −1,285.4 | −485.8 | −1,187.0 | −7,538.6 | — | — |
Pretax income | −36,069.7 | −36,069.7 | −43,067.8 | 18,379.6 | −553.2 | −13,531.1 | ▲16.2% | — |
Income tax | 0.0 | 0.0 | 2,870.0 | −2,265.0 | 0.0 | 0.0 | — | — |
Net incomePiotroski ROA ✕feeds Buffett Quality owner earnings | −36,069.7 | −36,069.7 | −45,729.2 | 20,617.9 | −680.8 | −13,531.1 | ▲21.1% | — |
| Per share | ||||||||
Diluted EPSbuyback-sensitive | −1.80 | −1.80 | −2.39 | 1.38 | −0.05 | −3.09 | ▲24.7% | — |
Diluted shares (mn) | 20.09 | 20.09 | 19.12 | 14.92 | 12.40 | 4.38 | ▲5.1% | +46.3% |
| Margins | ||||||||
Gross margin1st pct in Healthcare | −18.6% | −18.6% | −23.5% | 26.0% | 11.1% | 12.1% | ▲4.9pp | −30.7pp |
Operating margin | −59.9% | −59.9% | −68.6% | 13.8% | 0.5% | −11.7% | ▲8.7pp | −48.2pp |
Net margin28th pct in Healthcare | −63.3% | −63.3% | −75.1% | 15.0% | −0.6% | −26.5% | ▲11.8pp | −36.8pp |
Statements normalized in our fundamentals DB · Not investment advice.
Common questions
What was Synergetics USA's revenue last fiscal year?
Synergetics USA reported revenue of $57.0M in fiscal 2025, down 6.4% from fiscal 2024.
What was Synergetics USA's net income?
Synergetics USA reported net income of −$36.1M in fiscal 2025, a net margin of −63.3%.

